- Home
- TCBX vs CVRX Comparison
TCBX vs CVRX Comparison
Compare TCBX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- CVRX
- Stock Information
- Founded
- TCBX 2008
- CVRX 2000
- Country
- TCBX United States
- CVRX United States
- Employees
- TCBX N/A
- CVRX N/A
- Industry
- TCBX Banks
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TCBX Finance
- CVRX Health Care
- Exchange
- TCBX Nasdaq
- CVRX Nasdaq
- Market Cap
- TCBX 454.9M
- CVRX 419.8M
- IPO Year
- TCBX 2021
- CVRX 2021
- Fundamental
- Price
- TCBX $30.97
- CVRX $4.77
- Analyst Decision
- TCBX Hold
- CVRX Buy
- Analyst Count
- TCBX 4
- CVRX 7
- Target Price
- TCBX $33.67
- CVRX $14.50
- AVG Volume (30 Days)
- TCBX 72.3K
- CVRX 370.8K
- Earning Date
- TCBX 04-23-2025
- CVRX 05-08-2025
- Dividend Yield
- TCBX N/A
- CVRX N/A
- EPS Growth
- TCBX 44.43
- CVRX N/A
- EPS
- TCBX 2.95
- CVRX N/A
- Revenue
- TCBX $172,270,000.00
- CVRX $52,870,000.00
- Revenue This Year
- TCBX $17.61
- CVRX $22.17
- Revenue Next Year
- TCBX $6.52
- CVRX $24.02
- P/E Ratio
- TCBX $10.50
- CVRX N/A
- Revenue Growth
- TCBX 17.40
- CVRX 25.62
- 52 Week Low
- TCBX $18.82
- CVRX $5.81
- 52 Week High
- TCBX $39.45
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- TCBX 54.59
- CVRX 28.07
- Support Level
- TCBX $29.60
- CVRX $7.30
- Resistance Level
- TCBX $31.12
- CVRX $7.91
- Average True Range (ATR)
- TCBX 1.45
- CVRX 0.56
- MACD
- TCBX 0.33
- CVRX 0.12
- Stochastic Oscillator
- TCBX 91.50
- CVRX 4.36
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.